T2 Biosystems, Inc. (TTOO)
2024-09-30 | ||||
---|---|---|---|---|
Revenue from contract with customer, excluding assessed tax, total | 1,985 | |||
Selling, general and administrative expense | 5,378 | |||
Research and development expense | 2,667 | |||
Cost of goods and services sold | 4,101 | |||
Costs and expenses | 12,146 | |||
Operating income (loss) | -10,161 | |||
Other, net | 16 | |||
Interest expense to related party | 370 | |||
Change in fair value of derivative warrant liability | 321 | |||
Change in fair value of derivative related to term loan with related party | 77 | |||
Total other income (expense) | 44 | |||
Net loss | -10,117 | |||
Basic eps | -0.57 | |||
Diluted eps | -0.57 | |||
Basic average shares | 17,892,606 | |||
Diluted average shares | 17,892,606 |